Clinical Evaluation of BackStop in Patients Undergoing Intraureteric Stone Lithotripsy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00893282|
Recruitment Status : Completed
First Posted : May 5, 2009
Last Update Posted : May 5, 2009
The purpose of this clinical study is to evaluate BackStop, a polymer-based device that is intended to be used during ureteroscopic lithotripsy to prevent retrograde stone migration. It is a water soluble polymer with reverse thermosensitive properties; the polymer exists as a liquid at low temperature (below 17 C) and rapidly transitions to a high viscosity gel at body temperature (i.e. in the ureter). BackStop is injected above the stones in the ureter and is intended to prevent retrograde migration of stones during ureteroscopic lithotripsy. Upon completion of the lithotripsy procedure, BackStop dissolves naturally or by irrigation.
The study hypothesis is that a greater proportion of patients will experience no retropulsion of a kidney stone when BackStop is used versus no anti-retropulsion device when undergoing intracorporeal lithotripsy.
|Condition or disease||Intervention/treatment|
|Renal Calculi Kidney Stones||Device: BackStop Device: Intracorporeal lithotripsy without the use of an anti-retropulsion device|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||68 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Supportive Care|
|Official Title:||A Randomized, Controlled, Prospective, Single Blind Clinical Evaluation of BackStop in Patients Undergoing Intraureteric Stone Lithotripsy.|
|Study Start Date :||February 2008|
|Primary Completion Date :||November 2008|
|Study Completion Date :||December 2008|
Intracorporeal lithotripsy with the use of an anti-retropulsion device.
BackStop in a gel plug that potentially prevents retropulsion during intracorporeal lithotripsy.
Active Comparator: Control
No anti-retropulsion device will be used during lithotripsy.
|Device: Intracorporeal lithotripsy without the use of an anti-retropulsion device|
- Ability of BackStop™ to minimize migration stone fragments in the proximal ureter will and reported as "yes" or "no". [ Time Frame: intra-operative ]
- Extent of residual fragments remaining in ureter at the follow-up visit 2 to 4 weeks post-procedure. [ Time Frame: one month ]
- In the event that stone fragments migrate retrograde, there may be a need for the physician to employ additional procedures [ Time Frame: one month ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00893282
|McGill University Health Center|
|Montreal, Quebec, Canada, H3A1A1|